Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
KV Pharmaceutical Co. CL A (KV.A)
KV Pharmaceutical Co. CL A (KV.A) Actualités

KV.A

K V Pharma (KV.A)

KV Pharmaceutical Co. CL A

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:KV.A

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/09/2013	16h26	PR Newswire (US)	KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization	NYSE:KV.A	KV Pharmaceutical Co. CL A
24/01/2013	14h00	PR Newswire (US)	Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...	NYSE:KV.A	KV Pharmaceutical Co. CL A
28/12/2012	18h43	PR Newswire (US)	K-V Pharmaceutical Receives Court Approval of Hologic Settlement	NYSE:KV.A	KV Pharmaceutical Co. CL A
13/12/2012	00h39	PR Newswire (US)	K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...	NYSE:KV.A	KV Pharmaceutical Co. CL A
10/08/2012	14h00	PR Newswire (US)	K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
08/08/2012	17h09	PR Newswire (US)	K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
07/08/2012	18h16	PR Newswire (US)	K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
06/08/2012	13h57	PR Newswire (US)	K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
04/08/2012	06h56	PR Newswire (US)	K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations	NYSE:KV.A	KV Pharmaceutical Co. CL A
03/08/2012	17h27	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
31/07/2012	23h09	Edgar (US Regulatory)	Securities Registration Statement (S-1)	NYSE:KV.A	KV Pharmaceutical Co. CL A
26/07/2012	22h27	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
20/07/2012	22h05	PR Newswire (US)	K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
13/07/2012	22h43	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
06/07/2012	22h21	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
02/07/2012	15h15	PR Newswire (US)	FDA Issues Further Guidance About Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
30/06/2012	00h51	PR Newswire (US)	K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
18/06/2012	22h36	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	NYSE:KV.A	KV Pharmaceutical Co. CL A
18/06/2012	15h14	PR Newswire (US)	FDA and CMS Issue Important Updates on Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
25/05/2012	22h15	PR Newswire (US)	K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity	NYSE:KV.A	KV Pharmaceutical Co. CL A
16/05/2012	23h46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
12/04/2012	22h18	PR Newswire (US)	K-V Pharmaceutical Company to Present at Imperial Capital 2012 Healthcare Investor Forum	NYSE:KV.A	KV Pharmaceutical Co. CL A
02/04/2012	15h01	PR Newswire (US)	K-V Pharmaceutical Company to Present at Needham & Company 11th Annual Healthcare Conference	NYSE:KV.A	KV Pharmaceutical Co. CL A
14/02/2012	19h05	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
10/02/2012	23h01	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NYSE:KV.A	KV Pharmaceutical Co. CL A
09/02/2012	22h18	Edgar (US Regulatory)	Quarterly Report (10-Q)	NYSE:KV.A	KV Pharmaceutical Co. CL A
09/02/2012	13h30	PR Newswire (US)	K-V Pharmaceutical Announces Updated Makena® Performance Metrics and Investor Conference Call	NYSE:KV.A	KV Pharmaceutical Co. CL A
26/01/2012	21h30	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NYSE:KV.A	KV Pharmaceutical Co. CL A
19/12/2011	23h12	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (S-8)	NYSE:KV.A	KV Pharmaceutical Co. CL A
19/12/2011	22h09	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NYSE:KV.A	KV Pharmaceutical Co. CL A

Showing the most relevant articles for your search:NYSE:KV.A

1 2 3 Suivant >>

Cie de SaintGobain

JP Morgan Chase

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales